TY - JOUR
T1 - Drug metabolism and pancreatic cancer
AU - Flores, John Paul E.
AU - Diasio, Robert B.
AU - Saif, Muhammad Wasif
N1 - Publisher Copyright:
© 2016 Hellenic Society of Gastroenterology.
PY - 2017
Y1 - 2017
N2 - Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.
AB - Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.
KW - Chemotherapy
KW - Genomic profile
KW - Genomics
KW - Molecular pancreatic pathogenesis
KW - Pancreatic cancer pharmacogenomics
KW - Pancreatic exocrine cancer
KW - Targeted therapy
UR - http://www.scopus.com/inward/record.url?scp=85008204091&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008204091&partnerID=8YFLogxK
U2 - 10.20524/aog.2016.0074
DO - 10.20524/aog.2016.0074
M3 - Article
AN - SCOPUS:85008204091
SN - 1108-7471
VL - 30
SP - 54
EP - 61
JO - Annals of Gastroenterology
JF - Annals of Gastroenterology
IS - 1
ER -